Chemomab Therapeutics logo

Chemomab Therapeutics Share Price Today

(NASDAQ: CMMB)

Chemomab Therapeutics share price is $1.4 & ₹121.76 as on 6 Mar 2025, 2.30 'hrs' IST

$1.4

0.1

(7.69%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Chemomab Therapeutics share price in Dollar and Rupees. Guide to invest in Chemomab Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Chemomab Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Chemomab Therapeutics share price movements

  • Today's Low: $1.35
    Today's High: $1.44

    Day's Volatility :6.43%

  • 52 Weeks Low: $0.58
    52 Weeks High: $2.55

    52 Weeks Volatility :77.29%

Chemomab Therapeutics (CMMB) Returns

PeriodChemomab Therapeutics LtdSector (Health Care)Index (Russel 2000)
3 Months
-21.21%
2.1%
0.0%
6 Months
-43.23%
-4.1%
0.0%
1 Year
83.02%
2.2%
0.0%
3 Years
-63.17%
11.8%
-11.6%

Chemomab Therapeutics (CMMB) Key Statistics

in dollars & INR

Previous Close
$1.3
Open
$1.38
Today's High
$1.4427
Today's Low
$1.35
Market Capitalization
$31.5M
Today's Volume
$33.2K
52 Week High
$2.55
52 Week Low
$0.579
Revenue TTM
$0.0
EBITDA
$-15.3M
Earnings Per Share (EPS)
$-0.84
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-83.81%

How to invest in Chemomab Therapeutics Stock (CMMB) from India?

It is very easy for Indian residents to invest directly in Chemomab Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Chemomab Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Chemomab Therapeutics or CMMB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Chemomab Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Chemomab Therapeutics shares which would translate to 0.621 fractional shares of Chemomab Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Chemomab Therapeutics, in just a few clicks!

Returns in Chemomab Therapeutics (CMMB) for Indian investors in Rupees

The Chemomab Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Chemomab Therapeutics investment value today

Current value as on today

₹2,02,146

Returns

₹1,02,146

(+102.15%)

Returns from Chemomab Therapeutics Stock

₹97,183 (+97.18%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Chemomab Therapeutics (CMMB)

-22%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Chemomab Therapeutics Stock from India on INDmoney has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Chemomab Therapeutics

    Analyst Recommendation on Chemomab Therapeutics

    Buy

      75%Buy

      25%Hold

      0%Sell

    Based on 8 Wall street analysts offering stock ratings for Chemomab Therapeutics(by analysts ranked 0 to 5 stars)

    Based on 8 analyst
    • Current
    • 1M Ago
    • 3M Ago
    Buy
    6
    6
    6
    Hold
    2
    2
    2
    Sell
    0
    0
    0

    Analyst Forecast on Chemomab Therapeutics Stock (CMMB)

    What analysts predicted

    Upside of 542.86%

    Target:

    $9.00

    Current:

    $1.40

    Insights on Chemomab Therapeutics Stock (Ticker Symbol: CMMB)

    • Price Movement

      In the last 7 days, CMMB stock has moved down by -20.2%
    • CMMB vs VRTX (3 yr)

      In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 115.0%

    Chemomab Therapeutics Technicals Summary

    Sell

    Neutral

    Buy

    Chemomab Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

    Chemomab Therapeutics (CMMB) Vs Peers

    Company Name1 Month6 Month1 Year3 Years5 Years
    Chemomab Therapeutics Ltd logo
    -37.2%
    -43.23%
    83.02%
    -63.17%
    -99.43%
    Regeneron Pharmaceuticals, Inc. logo
    1.3%
    -41.29%
    -30.51%
    9.2%
    42.38%
    Beone Medicines Ltd logo
    15.19%
    34.31%
    61.3%
    43.16%
    68.1%
    Vertex Pharmaceuticals Incorporated logo
    3.37%
    3.77%
    18.06%
    106.43%
    121.36%
    Alnylam Pharmaceuticals, Inc. logo
    -11.52%
    -3.4%
    62.32%
    49.04%
    120.93%
    Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
    Chemomab Therapeutics Ltd logo
    NA
    NA
    NA
    -0.04
    -0.84
    -0.43
    NA
    0.87
    Regeneron Pharmaceuticals, Inc. logo
    17.85
    17.85
    1.03
    43.09
    0.16
    0.07
    0.01
    273.57
    Beone Medicines Ltd logo
    NA
    NA
    NA
    1.43
    -0.19
    -0.06
    NA
    31.22
    Vertex Pharmaceuticals Incorporated logo
    32.84
    NA
    1.33
    18.07
    -0.03
    0.13
    NA
    63.87
    Alnylam Pharmaceuticals, Inc. logo
    NA
    NA
    -0.49
    0.57
    -15.01
    -0.03
    NA
    0.52
    Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
    Chemomab Therapeutics Ltd logo
    Buy
    $31.5M
    -99.43%
    NA
    0.0%
    Regeneron Pharmaceuticals, Inc. logo
    Buy
    $74.9B
    42.38%
    17.85
    31.07%
    Beone Medicines Ltd logo
    NA
    $28.5B
    68.1%
    NA
    -16.92%
    Vertex Pharmaceuticals Incorporated logo
    Buy
    $124.1B
    121.36%
    32.84
    -4.86%
    Alnylam Pharmaceuticals, Inc. logo
    Buy
    $31.5B
    120.93%
    NA
    -12.37%

    About Chemomab Therapeutics

    Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, discovers and develops therapeutics for the treatment of fibrotic and inflammatory diseases in the United States. Its lead product candidate is CM-101, a humanized monoclonal antibody attenuates the basic function of CCL24 that is in phase 2 clinical trial for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). Chemomab Therapeutics Ltd. was founded in 2011 and is based in Tel Aviv, Israel.
    Organization
    Chemomab Therapeutics
    Employees
    0
    CEO
    Dr. Adi Mor George Ph.D.
    Industry
    Healthcare

    Management People of Chemomab Therapeutics

    NameTitle
    Dr. Adi Mor George Ph.D.
    Co-Founder, Chief Scientific Officer, CEO & Executive Director
    Ms. Sigal Fattal CPA, M.B.A.
    Chief Financial Officer
    Dr. Matthew B. Frankel M.B.A., M.D.
    Chief Medical Officer & VP of Drug Development
    Barbara Lindheim
    Consulting Vice President of Investor & Public Relations, Strategic Communications
    Mr. Jack Lawler
    Senior VP of Global Clinical Development Operations

    Important FAQs about investing in CMMB Stock from India :

    What is Chemomab Therapeutics share price today?

    Chemomab Therapeutics share price today stands at $1.40, Open: $1.38 ; Previous Close: $1.30 ; High: $1.44 ; Low: $1.35 ; 52 Week High: $2.55 ; 52 Week Low: $0.58.

    The stock opens at $1.38, after a previous close of $1.30. The stock reached a daily high of $1.44 and a low of $1.35, with a 52-week high of $2.55 and a 52-week low of $0.58.

    Can Indians buy Chemomab Therapeutics shares?

    Yes, Indians can invest in the Chemomab Therapeutics (CMMB) from India.

    With INDmoney, you can buy Chemomab Therapeutics at 0 brokerage. The step-by-step process is as follows:

    • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
    • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
    • Once funds are transferred successfully, you can buy Chemomab Therapeutics at zero transaction cost.

    How can I buy Chemomab Therapeutics shares from India?

    It is very easy to buy Chemomab Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

    Can Fractional shares of Chemomab Therapeutics (CMMB) be purchased?

    Yes, you can buy fractional shares of Chemomab Therapeutics with INDmoney app.

    What are the documents required to start investing in Chemomab Therapeutics stocks?

    To start investing in Chemomab Therapeutics, You will need the following documents:

    • Proof of Identification (PAN, Aadhaar etc)
    • Proof of address (Aadhaar, Voter ID etc)

    These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

    What are today’s High and Low prices of Chemomab Therapeutics Stock (CMMB)?

    Today’s highest price of Chemomab Therapeutics (CMMB) is $1.44.

    Today’s lowest price of Chemomab Therapeutics (CMMB) is $1.35.

    What is today's market capitalisation of Chemomab Therapeutics?

    Today's market capitalisation of Chemomab Therapeutics CMMB is 31.5M

    What is the 52 Week High and Low Range of Chemomab Therapeutics Stock (CMMB)?

    • 52 Week High

      $2.55

    • 52 Week Low

      $0.58

    What are the historical returns of Chemomab Therapeutics (CMMB)?

    • 1 Month Returns

      -37.2%

    • 3 Months Returns

      -43.23%

    • 1 Year Returns

      83.02%

    • 5 Years Returns

      -99.43%

    Who is the Chief Executive Officer (CEO) of Chemomab Therapeutics ?

    Dr. Adi Mor George Ph.D. is the current Chief Executive Officer (CEO) of Chemomab Therapeutics.